At the tumor level, high iron demand due to rapid proliferation, upregulation of transferrin receptor 1, and downregulation of ferroportin promote iron sequestration within tumor cells, reducing circulating iron (41, 137). This evidence concerns the gene SLC40A1 and neoplasm.